Phylogenetic classification of serotype III group B streptococci on the basis of hylB gene analysis and DNA sequences specific to restriction digest pattern type III-3

Journal of Infectious Diseases

Volumn 183, Issue 11, 2001, Pages 1694-1697

  Bohnsack, John F ^a   Takahashi, Shinji ^c   Detrick, Shauna R ^a   Pelinka, Leslie R ^a   Hammitt, Laura L ^a   Aly, Adrienne A ^a   Whiting, April A ^a   Adderson, Elisabeth E ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c Joshi Eiyoh University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; HYALURONATE LYSASE; HYALURONIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA RESTRICTION; DNA SEQUENCE; ENZYME ACTIVITY; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTYPE; STRAIN DIFFERENCE; STREPTOCOCCUS AGALACTIAE;

BLOTTING, SOUTHERN; DNA RESTRICTION ENZYMES; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; HUMANS; NUCLEIC ACID HYBRIDIZATION; PHYLOGENY; POLYSACCHARIDE-LYASES; SEQUENCE ANALYSIS, DNA; STREPTOCOCCUS; VIRULENCE;

EID: 0035370283     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/320717     Document Type: Article

References (15)

1. Baker CJ, Edwards MS. Group B streptococcal infections, In: Remington JS, Klein JO, eds. Infectious disease of the fetus and newborn infant, 5th ed. Philadelphia: WB Saunders 2000:1091-156.
2. Takahashi, S, Adderson EE, Nagano Y, Briesacher MR, Bohnsack JF. Identification of a highly encapsulated, genetically related group of invasive type III group B streptococci. J Infect Dis 1998; 177:1116-9.
3. Pritchard DG, Lin B. Group B streptococcal neuraminidase is actually a hyaluronidase. Infect Immun 1993; 61:3234-9.
4. Milligan TW, Baker CJ, Strauss DC, Mattingly SJ. Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci. Infect Immun 1978; 21:738-46.
5. Musser JM, Mattingly SJ, Quentin R, Goudeau A, Selander RK. Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. Proc Natl Acad Sci USA 1989; 86:4731-5.
6. Rolland K, Marois C, Siquier V, Cattier B, Quentin R. Genetic features of Streptococcus agalactiae strains causing severe neonatal infections, as revealed by pulsed-field gel electrophoresis and hylB gene analysis. J Clin Microbiol 1999; 37:1892-8.
7. Granlund M, Oberg L, Sellin M, Norgren M. Identification of a novel insertion element. IS1548, in group B streptococci, predominantly in strains causing endocarditis. J Infect Dis 1998; 177:967-76.
8. Smith RF, Willett NP. Rapid plate method for screening hyaluronidase and chondroitin sulfatase-producing microorganisms. Appl Microbiol 1968; 16:1434-6.
9. Lisitsyn N, Lisitsyn N, Wigler M. Cloning the differences between two complex genomes. Science 1993; 259:946-51.
10. Adderson EE, Takahashi S, et al. Chromosomal mapping of genes unique to the virulent III-3 subtype of type III group B streptococcus. In: Proceedings of the XIV Lancefield International Symposium on Streptococci and Streptococcal Diseases (Auckland, New Zealand, 1999), Porirua, New Zealand: Institute for Environmental Science and Research, 2000.
11. Coffey TJ, Enright MC, Daniels M, et al. Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumontae. Mol Microbiol 1998; 27:73-83.
12. Szilak L, Venetianer P, Kiss A. Cloning and nucleotide sequence of the genes coding for the Sau961 restriction and modification enzymes. Nucleic Acids Res 1990; 18:4659-64.
13. Quentin R, Huet H, et al. Characterization of Streptococcus agalactiae strains by multilocus enzyme genotype and serotype: identification of multiple virulent clone families that cause invasive disease. J Clin Microbiol 1995; 33:2576-81.
14. Hauge M, Jespersgaard C, Poulsen K, Kilian M. Population structure of Streptococcus agalactiae reveals an association between specific evolutionary lineages and putative virulence factors but not disease. Infect Immun 1996; 64:919-25.
15. Takahashi S, Aoyagi Y, Adderson EE, Okuwaki Y, Bohnsack JF. Capsular sialic acid limits C5a production on type III group B streptococci. Infect Immun 1999; 67:1866-70.